Koyfin Home > Directory > Health Care > Adma Biologics > Debt Repaid

Adma Biologics Debt Repaid Chart (ADMA)

Adma Biologics annual/quarterly Debt Repaid from 2010 to 2020.
  • Adma Biologics Debt Repaid for the quarter ending June 06, 2020 was $0m a 4.92% decrease of 0m year over year
  • Adma Biologics Debt Repaid for the last 12 months ending June 06, 2020 was $0m a -96,744.31% increase of 30m year over year
  • Adma Biologics Annual Debt Repaid for 2019 was $-30m a 99.88% decrease of -30m from 2018
  • Adma Biologics Annual Debt Repaid for 2018 was $0m a -55,075.48% increase of 20m from 2017
  • Adma Biologics Annual Debt Repaid for 2017 was $-20m a 99.92% decrease of -20m from 2016
Other Cash Flow Metrics:
  • Adma Biologics Cash Flow from Operations for the quarter ending December 12, 2018 was $-19m a 12.55% decrease of -2m year over year
  • Adma Biologics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-14m a 28.03% decrease of -4m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Debt Repaid Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$-30m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual ADMA Debt Repaid Data

2019$-30m
2018$0m
2017$-20m
2016$0m
2015$-15m
2014$0m
2013$0m
2012$0m
2011$0m
2010$0m